Podiatrists in Thibodaux, LA Accepting Medicare

5 Podiatrists found. Showing 1 - 5

Thibodaux Regional Foot & Ankle Center Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 290 Bowie Rd, Thibodaux, LA 70301 Phone: 985-493-4990    Fax: 985-493-4991

Elizabeth Ann Ansert, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 290 Bowie Rd, Thibodaux, LA 70301 Phone: 985-493-4990

Dr. Bryon Mckenna, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 290 Bowie Rd, Thibodaux, LA 70301 Phone: 985-493-4990    Fax: 985-493-4991

Dr. Eric Matthew Swenson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 290 Bowie Rd, Thibodaux, LA 70301 Phone: 985-493-4990    Fax: 985-493-4991

Dr. Phillip Barrett Corona, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 970 S Acadia Rd, Thibodaux, LA 70301 Phone: 985-446-2335    Fax: 985-446-2337

News Archive

Acoustic cardiography improves diagnostic accuracy in acute heart failure

It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.

Study: Only one-third of patients receive living donor kidney transplant pre-emptively

A kidney transplant is a life-changing and life-saving procedure. Yet, a new study conducted by Mayo Clinic and the University of Michigan shows that only one-third of patients who ultimately receive a living donor kidney transplant receive it pre-emptively (i.e., before starting dialysis). Less than two-thirds receive a transplant either pre-emptively or within a year of starting dialysis.

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.

Penn chemists find potential ways to use methane in pharmaceuticals, value-added substances

Methane is the world's most abundant hydrocarbon. It's the major component of natural gas and shale gas and, when burned, is an effective fuel. But it's also a major contributor to climate change, with 24 times greater potency as a greenhouse gas than carbon dioxide.

Teva Pharmaceutical Industries reaches settlement in principle to resolve claims under federal, state False Claims Acts

Teva Pharmaceutical Industries Ltd. announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts.

Read more Medical News

› Verified 2 days ago